Global HLA Typing Transplant Market 2017-2021
About HLA Typing Transplant
Human leukocyte antigen (HLA) is located in the chromosome 6, which is present in almost all nucleated cells. The HLA system includes a complex array of genes, which controls the immune response through recognition of self and non-self antigens, which can lead to graft rejection. HLA typing, also known as tissue typing, is required majorly to examine graft rejection due to organ, tissue, blood cell, and bone marrow transplantation. Through this testing, bone marrow and blood cell transplantation complications can be minimized, which can increase the survival rate of the organ recipient.
Technavio’s analysts forecast the global HLA typing transplant market to grow at a CAGR of 9.20% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global HLA typing transplant market for 2017-2021. To calculate the market size, the report considers revenue generated by the sales of products such as systems, assays, and accessories.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global HLA Typing Transplant Market 2017-2021
Technavio recognizes the following companies as the key players in the global HLA typing transplant market: Immucor, Illumina and Thermo Fisher Scientific.
Other Prominent Vendors in the market are: Biofortuna, Bio-Rad Laboratories, Cellular Technology, GenDx, HistoGenetics, InGen, Linkage Biosciences, Omixon, Pacific Biosciences of California and STRATEC Biomedical.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is new government initiatives for HLA typing. The growing concerns about hepatitis and HIV are leading the government to develop few standards and strategies to reduce the number of communicable diseases through transplantation. Quality measurement in government-introduced programs lead to increased adoption of bone marrow and umbilical cord transplantation.”
According to the report, one driver in the market is growing incidence of organ failure. The demand for tissue and organs such as bone marrow, heart, liver, kidney, and lungs is very high worldwide. The increasing rate of alcohol consumption, unhealthy lifestyles and food habits, and drug intake are the leading causes of organ failure. In addition, the rise in older adult population results in increased demand for organs for transplantation. According to a combined study conducted by the Department of Internal Medicine, Division of Hepatology, Loyola University Medical Center; Department of Preventive Health Sciences, Stritch School of Medicine, Loyola University Chicago; and Division of Gastroenterology and Hepatology, University of Michigan Health System, in 2015, liver cirrhosis is one of the major factors of death in the US.
Further, the report states that one challenge in the market is ethical challenges in organ transplantation. The unavailability of organs is one of the leading challenges in the market. This leads many companies and universities to research and focus on developing artificial organs. However, owing to the disparity on ethical and legal rights, the adoption and donation of organs have been affected negatively. For instance, the detection of a genetic defect is conducted through preimplantation genetic screening (PGS) through in-vitro fertilization. In such cases, physicians use allogenic haematopoietic stem cell transplantation for children who are suffering from severe leukemia, beta-thalassaemia, and Diamond–Blackfan anaemia.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit- https://www.technavio.com/report/global-hla-typing-transplant-market-2017-2021
Immucor, Illumina, Thermo Fisher Scientific, Biofortuna, Bio-Rad Laboratories, Cellular Technology, GenDx, HistoGenetics, InGen, Linkage Biosciences, Omixon, Pacific Biosciences of California and STRATEC Biomedical.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook